Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    11551579 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV
Conditions: HIV Infections;   Hepatitis B
Interventions: Drug: Adefovir dipivoxil;   Drug: Tenofovir disoproxil fumarate
2 Approved for marketing An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options
Condition: Chronic Hepatitis B
Intervention: Drug: Adefovir Dipivoxil
3 Withdrawn Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)
Conditions: HIV Infections;   Hepatitis B;   Hepatitis C
Interventions: Drug: Adefovir dipivoxil;   Drug: Peginterferon-alfa-2A;   Drug: Ribavirin;   Procedure: Liver Biopsy

Indicates status has not been verified in more than two years